28:@0.092505:0.957873:0.109687:0.957873:0.109687:0.938882:0.092505:0.938882:0.008591:0.008591
CHAPTER 2:@0.117647:0.067123:0.190298:0.067123:0.190298:0.047044:0.117647:0.047044:0.009172:0.009650:0.008799:0.008861:0.007388:0.007906:0.009359:0.003320:0.008197
2:@0.038824:0.247137:0.060302:0.247137:0.060302:0.199659:0.038824:0.199659:0.021478
heterogeneity. n = number of analyzed metaphase spread, from left to right: 24, 33, 14, 20, 24, 40, 22, 48 and :@0.117647:0.118163:0.856322:0.118163:0.856322:0.101494:0.117647:0.101494:0.009245:0.007471:0.005080:0.007396:0.006089:0.009039:0.007900:0.007396:0.009488:0.007396:0.004314:0.005267:0.006537:0.003679:0.003464:0.009618:0.003474:0.009637:0.003464:0.009320:0.009338:0.014231:0.009207:0.007396:0.006387:0.003464:0.008871:0.005080:0.003464:0.007433:0.009562:0.007695:0.004240:0.007956:0.007228:0.007452:0.009320:0.003464:0.014306:0.007471:0.005360:0.007209:0.009133:0.009320:0.007601:0.006443:0.007396:0.003464:0.006145:0.009058:0.006089:0.007601:0.007601:0.009095:0.003679:0.003464:0.005248:0.006089:0.008871:0.014437:0.003464:0.004240:0.007396:0.005071:0.005071:0.003474:0.005080:0.009039:0.003464:0.006387:0.004594:0.008124:0.009077:0.005267:0.003679:0.003464:0.008535:0.008535:0.003679:0.003464:0.008535:0.008535:0.003679:0.003464:0.008535:0.008535:0.003679:0.003464:0.008535:0.008535:0.003679:0.003464:0.008535:0.008535:0.003679:0.003464:0.008535:0.008535:0.003679:0.003464:0.008535:0.008535:0.003679:0.003464:0.008535:0.008535:0.003464:0.007433:0.009490:0.009320:0.003362
14. :@0.117647:0.132715:0.141758:0.132715:0.141758:0.116046:0.117647:0.116046:0.008535:0.008535:0.003679:0.003362
(B) :@0.142733:0.132715:0.169758:0.132715:0.169758:0.115425:0.142733:0.115425:0.006238:0.011262:0.006238:0.003287
Genome-wide CNV analysis of tumor and organoid pairs. For each sample, CNV profile of blood :@0.170711:0.132715:0.856249:0.132715:0.856249:0.116046:0.170711:0.116046:0.012943:0.007396:0.009488:0.008871:0.014306:0.007396:0.006163:0.012046:0.004538:0.009264:0.007396:0.004333:0.012009:0.013279:0.012345:0.004333:0.007433:0.009562:0.007695:0.004240:0.007956:0.006219:0.004594:0.006275:0.004333:0.008871:0.005080:0.004333:0.005043:0.009338:0.014306:0.008871:0.006387:0.004333:0.007433:0.009488:0.009320:0.004333:0.008871:0.006238:0.008068:0.007433:0.009490:0.008871:0.004538:0.009320:0.004333:0.009299:0.007435:0.004594:0.006238:0.006275:0.003679:0.004333:0.008741:0.008871:0.006387:0.004333:0.007599:0.007601:0.007172:0.009376:0.004333:0.006499:0.007433:0.014138:0.009133:0.004240:0.007155:0.003679:0.004333:0.012009:0.013279:0.012345:0.004333:0.009058:0.006089:0.008871:0.004650:0.004762:0.004240:0.007396:0.004333:0.008871:0.005080:0.004333:0.008927:0.004240:0.009224:0.009226:0.009320:0.003362
germline reference (orange), tumor (black) and organoids (pink) are displayed. CNVs observed in original :@0.117647:0.147267:0.856295:0.147267:0.856295:0.130598:0.117647:0.130598:0.007900:0.007396:0.006387:0.014530:0.004296:0.004594:0.009488:0.007396:0.003941:0.006089:0.007396:0.004931:0.007396:0.006089:0.007396:0.009488:0.007359:0.007396:0.003941:0.005678:0.008871:0.006462:0.007433:0.009376:0.007900:0.007396:0.005678:0.003679:0.003941:0.005043:0.009338:0.014306:0.008871:0.006387:0.003941:0.005678:0.008925:0.004445:0.007601:0.007172:0.008610:0.005678:0.003941:0.007433:0.009488:0.009320:0.003941:0.008871:0.006238:0.008068:0.007433:0.009488:0.008871:0.004538:0.009320:0.006275:0.003941:0.005678:0.009058:0.004594:0.009712:0.008610:0.005678:0.003941:0.007433:0.006089:0.007396:0.003941:0.009320:0.004594:0.006145:0.009133:0.004445:0.007302:0.007788:0.007452:0.009095:0.003679:0.003941:0.012009:0.013279:0.012345:0.006275:0.003941:0.008965:0.008946:0.006443:0.007396:0.006871:0.007881:0.007452:0.009320:0.003941:0.004594:0.009618:0.003941:0.008869:0.006387:0.004594:0.008068:0.004594:0.009562:0.007695:0.004296:0.003362
tumor samples are maintained in organoid lines. MBT-2.2 organoid line displays a relatively flat CNV :@0.117647:0.161819:0.856342:0.161819:0.856342:0.145151:0.117647:0.145151:0.005043:0.009338:0.014306:0.008871:0.006387:0.006238:0.006499:0.007433:0.014138:0.009133:0.004240:0.007396:0.006275:0.006238:0.007435:0.006089:0.007396:0.006238:0.014381:0.007433:0.004594:0.009320:0.005360:0.007433:0.004594:0.009488:0.007452:0.009320:0.006238:0.004594:0.009618:0.006238:0.008871:0.006238:0.008068:0.007433:0.009488:0.008873:0.004538:0.009320:0.006238:0.004296:0.004594:0.009488:0.007396:0.006275:0.003679:0.006238:0.016043:0.010141:0.009656:0.006163:0.008535:0.003679:0.008535:0.006238:0.008873:0.006236:0.008068:0.007435:0.009488:0.008871:0.004538:0.009320:0.006238:0.004296:0.004594:0.009488:0.007396:0.006238:0.009320:0.004594:0.006145:0.009133:0.004445:0.007302:0.007956:0.006275:0.006238:0.007601:0.006238:0.006089:0.007321:0.004445:0.007209:0.005267:0.004538:0.007881:0.007321:0.004240:0.007956:0.006238:0.004613:0.004761:0.007209:0.005267:0.006238:0.012009:0.013279:0.012345:0.003362
pattern in accordance with MBT-2.1 that was derived from the same patient and shows normal metaphase :@0.117647:0.176371:0.856378:0.176371:0.856378:0.159702:0.117647:0.159702:0.009301:0.007209:0.005043:0.005080:0.007396:0.006387:0.009618:0.003903:0.004594:0.009618:0.003903:0.007601:0.007359:0.007359:0.008871:0.006089:0.009469:0.007433:0.009488:0.007359:0.007396:0.003903:0.012046:0.004314:0.005416:0.009376:0.003903:0.016043:0.010141:0.009656:0.006163:0.008535:0.003679:0.008535:0.003903:0.005416:0.009320:0.007209:0.005267:0.003903:0.012046:0.007601:0.006275:0.003903:0.009264:0.007396:0.006387:0.004538:0.007881:0.007452:0.009320:0.003903:0.005248:0.006089:0.008871:0.014437:0.003903:0.005416:0.009245:0.007396:0.003903:0.006499:0.007433:0.014306:0.007396:0.003903:0.009301:0.007209:0.005267:0.004538:0.007396:0.009320:0.005267:0.003903:0.007435:0.009488:0.009320:0.003903:0.006182:0.009245:0.008890:0.012046:0.006275:0.003903:0.009488:0.008871:0.006387:0.014381:0.007695:0.004296:0.003903:0.014306:0.007471:0.005360:0.007209:0.009133:0.009320:0.007601:0.006443:0.007396:0.003362
spreads (in Figure 2a). HGS lines display extreme CNV abnormalities (see also Extended Data Figure 4). :@0.117647:0.190923:0.828807:0.190923:0.828807:0.174255:0.117647:0.174255:0.006145:0.009058:0.006089:0.007601:0.007601:0.009320:0.006275:0.002951:0.005678:0.004594:0.009618:0.002951:0.009320:0.004594:0.008068:0.009338:0.006089:0.007396:0.002951:0.008535:0.007601:0.005678:0.003679:0.002951:0.013428:0.012831:0.008274:0.002951:0.004296:0.004594:0.009488:0.007396:0.006275:0.002951:0.009320:0.004594:0.006145:0.009133:0.004445:0.007302:0.007956:0.002951:0.007450:0.008255:0.005267:0.006089:0.007396:0.014306:0.007396:0.002951:0.012009:0.013279:0.012345:0.002951:0.007452:0.008853:0.009488:0.008871:0.006387:0.014381:0.007695:0.004296:0.004314:0.005267:0.004538:0.007396:0.006275:0.002951:0.005678:0.006443:0.007452:0.007396:0.002951:0.007695:0.004296:0.006443:0.009039:0.002951:0.009955:0.008255:0.005080:0.007396:0.009488:0.009264:0.007452:0.009320:0.002951:0.013260:0.007209:0.005360:0.007601:0.002951:0.009320:0.004594:0.008068:0.009338:0.006089:0.007396:0.002951:0.008535:0.005678:0.003679:0.003362
(C):@0.828381:0.190923:0.852941:0.190923:0.852941:0.173633:0.828381:0.173633:0.006238:0.012084:0.006238
 :@0.852941:0.190923:0.856302:0.190923:0.856302:0.174255:0.852941:0.174255:0.003362
Genome-wide CNV analysis of early (organoids 1st) and late (organoids 2nd) passage organoid pairs (HGS-:@0.117647:0.205476:0.852941:0.205476:0.852941:0.188807:0.117647:0.188807:0.012943:0.007396:0.009488:0.008871:0.014306:0.007396:0.006163:0.012046:0.004538:0.009264:0.007396:0.003033:0.012009:0.013279:0.012345:0.003033:0.007435:0.009562:0.007695:0.004240:0.007956:0.006219:0.004594:0.006275:0.003033:0.008871:0.005080:0.003033:0.007601:0.007433:0.006219:0.004240:0.007956:0.003035:0.005678:0.008871:0.006238:0.008068:0.007433:0.009488:0.008871:0.004538:0.009320:0.006275:0.003033:0.008535:0.006145:0.005267:0.005678:0.003033:0.007435:0.009488:0.009320:0.003033:0.004445:0.007209:0.005080:0.007396:0.003033:0.005678:0.008871:0.006238:0.008068:0.007433:0.009488:0.008871:0.004538:0.009320:0.006275:0.003035:0.008535:0.009488:0.009320:0.005678:0.003033:0.009301:0.007601:0.006163:0.006499:0.007527:0.007900:0.007396:0.003033:0.008871:0.006238:0.008068:0.007433:0.009488:0.008871:0.004538:0.009320:0.003035:0.009301:0.007433:0.004594:0.006238:0.006275:0.003033:0.005678:0.013428:0.012831:0.008274:0.006163
2, passage six versus passage 15; HGS-6, passage eight versus passage 21). A ploidy of three was assumed for :@0.117647:0.220027:0.856419:0.220027:0.856419:0.203359:0.117647:0.203359:0.008535:0.003679:0.003399:0.009299:0.007601:0.006163:0.006499:0.007527:0.007900:0.007396:0.003399:0.006219:0.004594:0.008255:0.003399:0.007881:0.007396:0.006238:0.006145:0.009338:0.006275:0.003399:0.009299:0.007601:0.006163:0.006499:0.007527:0.007900:0.007396:0.003399:0.008535:0.008535:0.003679:0.003399:0.013428:0.012831:0.008274:0.006163:0.008535:0.003679:0.003390:0.009301:0.007601:0.006163:0.006499:0.007527:0.007900:0.007396:0.003390:0.007396:0.004594:0.008124:0.009077:0.005267:0.003399:0.007881:0.007396:0.006238:0.006145:0.009338:0.006275:0.003399:0.009301:0.007601:0.006163:0.006499:0.007527:0.007900:0.007396:0.003390:0.008535:0.008535:0.005678:0.003679:0.003399:0.012214:0.003399:0.009131:0.004240:0.008873:0.004537:0.009265:0.007956:0.003399:0.008871:0.005080:0.003399:0.005416:0.009376:0.006089:0.007452:0.007396:0.003399:0.012046:0.007601:0.006275:0.003399:0.007601:0.006163:0.006145:0.009338:0.014308:0.007450:0.009320:0.003399:0.004931:0.008871:0.006387:0.003362
this sample. For each sample, CNV profile of blood germline reference (orange), early (pink) and late (blue) :@0.117647:0.234580:0.856262:0.234580:0.856262:0.217911:0.117647:0.217911:0.005416:0.009376:0.004594:0.006275:0.003474:0.006499:0.007433:0.014138:0.009133:0.004240:0.007153:0.003679:0.003474:0.008741:0.008871:0.006387:0.003474:0.007601:0.007601:0.007172:0.009376:0.003474:0.006499:0.007433:0.014138:0.009133:0.004240:0.007153:0.003679:0.003474:0.012009:0.013279:0.012345:0.003474:0.009058:0.006089:0.008871:0.004650:0.004762:0.004240:0.007396:0.003474:0.008871:0.005080:0.003474:0.008927:0.004240:0.009226:0.009226:0.009320:0.003474:0.007900:0.007396:0.006387:0.014530:0.004296:0.004594:0.009488:0.007396:0.003474:0.006089:0.007396:0.004929:0.007396:0.006089:0.007396:0.009490:0.007359:0.007396:0.003474:0.005678:0.008871:0.006462:0.007433:0.009376:0.007900:0.007396:0.005678:0.003679:0.003474:0.007601:0.007433:0.006219:0.004240:0.007956:0.003474:0.005678:0.009056:0.004594:0.009712:0.008610:0.005678:0.003474:0.007433:0.009488:0.009320:0.003474:0.004445:0.007209:0.005080:0.007396:0.003474:0.005678:0.008927:0.004015:0.009282:0.007396:0.005678:0.003362
passaged organoid are displayed. CNV profiles observed in organoid samples are maintained.:@0.117647:0.249132:0.757237:0.249132:0.757237:0.232463:0.117647:0.232463:0.009301:0.007601:0.006163:0.006499:0.007527:0.007900:0.007452:0.009320:0.003362:0.008871:0.006238:0.008068:0.007433:0.009488:0.008871:0.004538:0.009320:0.003362:0.007433:0.006089:0.007396:0.003362:0.009320:0.004594:0.006143:0.009135:0.004443:0.007302:0.007790:0.007450:0.009095:0.003679:0.003362:0.012009:0.013279:0.012345:0.003362:0.009058:0.006089:0.008871:0.004650:0.004762:0.004240:0.007396:0.006275:0.003362:0.008965:0.008946:0.006443:0.007396:0.006871:0.007881:0.007452:0.009320:0.003362:0.004594:0.009618:0.003362:0.008871:0.006238:0.008068:0.007433:0.009488:0.008871:0.004538:0.009320:0.003362:0.006499:0.007433:0.014138:0.009133:0.004240:0.007396:0.006275:0.003362:0.007433:0.006089:0.007396:0.003362:0.014381:0.007433:0.004594:0.009320:0.005360:0.007433:0.004594:0.009488:0.007452:0.009095:0.003679
 :@0.117647:0.263684:0.121009:0.263684:0.121009:0.247015:0.117647:0.247015:0.003362
Figure 3: Somatic mutations and amplifications/deletions in OC organoids. :@0.117647:0.642038:0.685538:0.642038:0.685538:0.624747:0.117647:0.624747:0.009488:0.005080:0.008797:0.009730:0.006761:0.007751:0.005864:0.008927:0.004445:0.005864:0.008927:0.009264:0.014810:0.007807:0.005752:0.005155:0.007527:0.005864:0.014717:0.009730:0.005773:0.007807:0.005752:0.005153:0.009264:0.009786:0.006574:0.005864:0.007900:0.009955:0.009712:0.005864:0.007900:0.014717:0.009637:0.004781:0.005080:0.004949:0.005022:0.007695:0.007807:0.005752:0.005155:0.009264:0.009786:0.006574:0.005808:0.009786:0.007601:0.004856:0.007844:0.005752:0.005153:0.009265:0.009786:0.006574:0.005864:0.005080:0.009955:0.005864:0.013875:0.012084:0.005864:0.009264:0.006929:0.008591:0.007900:0.009955:0.009264:0.005155:0.009656:0.006649:0.004445:0.003287
Somatic mutations and :@0.688176:0.642038:0.856302:0.642038:0.856302:0.625369:0.688176:0.625369:0.008666:0.008871:0.014381:0.007209:0.005267:0.004538:0.007359:0.006004:0.014138:0.009058:0.005360:0.007209:0.005267:0.004538:0.008871:0.009506:0.006275:0.006004:0.007433:0.009488:0.009320:0.003362
amplifications/deletions in relevant genes of ovarian cancer. For each sample, tumor/organoid pairs are :@0.117647:0.656590:0.856378:0.656590:0.856378:0.639921:0.117647:0.639921:0.007433:0.014138:0.009133:0.004296:0.004594:0.004650:0.004594:0.007452:0.007209:0.005267:0.004538:0.008871:0.009506:0.006275:0.005808:0.009264:0.007321:0.004240:0.007471:0.005267:0.004538:0.008871:0.009506:0.006275:0.005920:0.004594:0.009618:0.005920:0.006089:0.007321:0.004240:0.007637:0.008050:0.007433:0.009321:0.005267:0.005920:0.007900:0.007396:0.009488:0.007396:0.006275:0.005920:0.008871:0.005080:0.005920:0.008890:0.008050:0.007433:0.006387:0.004742:0.007435:0.009618:0.005920:0.007450:0.007433:0.009490:0.007359:0.007396:0.005117:0.003679:0.005911:0.008742:0.008871:0.006387:0.005911:0.007601:0.007601:0.007172:0.009376:0.005920:0.006499:0.007433:0.014138:0.009133:0.004240:0.007155:0.003679:0.005911:0.005045:0.009338:0.014306:0.008871:0.006387:0.005808:0.008873:0.006238:0.008068:0.007435:0.009488:0.008871:0.004538:0.009320:0.005920:0.009301:0.007433:0.004594:0.006238:0.006275:0.005920:0.007433:0.006090:0.007396:0.003362
displayed and indicated by color coding (black, tumors; pink, organoids; blue, organoids re-sequenced and :@0.117647:0.671142:0.856355:0.671142:0.856355:0.654473:0.117647:0.654473:0.009320:0.004594:0.006145:0.009133:0.004445:0.007302:0.007788:0.007452:0.009320:0.003791:0.007433:0.009488:0.009320:0.003791:0.004594:0.009488:0.009320:0.004538:0.007452:0.007209:0.005080:0.007450:0.009320:0.003791:0.008871:0.007956:0.003791:0.007359:0.008946:0.004240:0.008871:0.006387:0.003791:0.007359:0.009226:0.009320:0.004594:0.009376:0.008068:0.003791:0.005678:0.008925:0.004445:0.007601:0.007174:0.008610:0.003679:0.003791:0.005043:0.009338:0.014306:0.008873:0.006236:0.006275:0.003679:0.003791:0.009058:0.004594:0.009712:0.008610:0.003679:0.003791:0.008871:0.006238:0.008068:0.007433:0.009488:0.008871:0.004538:0.009320:0.006275:0.003679:0.003791:0.008927:0.004015:0.009282:0.007153:0.003679:0.003791:0.008871:0.006238:0.008068:0.007433:0.009488:0.008871:0.004538:0.009320:0.006275:0.003791:0.006089:0.007396:0.006163:0.006443:0.007450:0.008759:0.009284:0.007396:0.009488:0.007359:0.007450:0.009320:0.003791:0.007433:0.009490:0.009320:0.003362
analyzed after extended passaging). Passage number at which organoid lines were sequenced is given in :@0.117647:0.685694:0.856301:0.685694:0.856301:0.669026:0.117647:0.669026:0.007433:0.009562:0.007695:0.004240:0.007956:0.007228:0.007452:0.009320:0.005461:0.007433:0.005071:0.004884:0.007396:0.006387:0.005463:0.007452:0.008255:0.005078:0.007396:0.009490:0.009264:0.007452:0.009320:0.005461:0.009301:0.007601:0.006163:0.006499:0.007527:0.008068:0.004594:0.009376:0.008068:0.005678:0.003679:0.005461:0.009338:0.007601:0.006163:0.006499:0.007525:0.007902:0.007396:0.005461:0.009320:0.009338:0.014231:0.009207:0.007396:0.006387:0.005461:0.007209:0.005267:0.005463:0.012100:0.009376:0.004540:0.007172:0.009376:0.005461:0.008871:0.006238:0.008068:0.007433:0.009488:0.008871:0.004538:0.009320:0.005461:0.004296:0.004594:0.009490:0.007396:0.006275:0.005461:0.011878:0.007396:0.006089:0.007396:0.005461:0.006443:0.007452:0.008759:0.009282:0.007396:0.009488:0.007359:0.007452:0.009320:0.005461:0.004594:0.006275:0.005461:0.008068:0.004537:0.007883:0.007396:0.009618:0.005463:0.004594:0.009618:0.003362
Supplementary Table 7.:@0.117647:0.700246:0.279049:0.700246:0.279049:0.683578:0.117647:0.683578:0.008012:0.009058:0.009039:0.009133:0.004240:0.007396:0.014306:0.007396:0.009320:0.005360:0.007433:0.006873:0.007956:0.003362:0.008927:0.007452:0.008927:0.004240:0.007396:0.003362:0.008535:0.003679
OC organoids capture tumor heterogeneity:@0.117647:0.755428:0.505415:0.755428:0.505415:0.732268:0.117647:0.732268:0.011256:0.011007:0.003984:0.011256:0.011081:0.011056:0.010558:0.011679:0.011256:0.004856:0.011231:0.010409:0.003984:0.010905:0.010558:0.010633:0.008616:0.011156:0.011231:0.009363:0.003984:0.008616:0.011156:0.014817:0.011256:0.011231:0.003984:0.011579:0.009363:0.008616:0.009363:0.011079:0.011256:0.011206:0.009363:0.011679:0.009363:0.004856:0.008616:0.010309
To  assess  whether  organoids  capture  intrapatient  heterogeneity,  we  compared  or-:@0.117647:0.798968:0.852941:0.798968:0.852941:0.778595:0.117647:0.778595:0.010866:0.011048:0.004109:0.006492:0.009291:0.007533:0.007875:0.009039:0.007533:0.007670:0.004109:0.006494:0.014789:0.011299:0.009131:0.006620:0.011299:0.009039:0.007807:0.004109:0.006494:0.010843:0.007624:0.009861:0.009085:0.011596:0.010843:0.005547:0.011391:0.007670:0.004109:0.006492:0.009108:0.008811:0.011048:0.006163:0.011413:0.007442:0.009039:0.004109:0.006492:0.005615:0.011391:0.006437:0.007898:0.008811:0.011368:0.008811:0.006437:0.005547:0.009039:0.011391:0.006437:0.004109:0.006494:0.011299:0.009131:0.006209:0.009039:0.007442:0.011048:0.009656:0.009039:0.011596:0.009039:0.005273:0.006437:0.007989:0.004497:0.004109:0.006494:0.014518:0.009039:0.004109:0.006492:0.008994:0.010843:0.017280:0.011368:0.009085:0.007442:0.009108:0.011391:0.004109:0.006494:0.010843:0.007234:0.007533
ganoid lines derived from one primary and three metastatic sites of a patient diag-:@0.117647:0.819547:0.852941:0.819547:0.852941:0.799174:0.117647:0.799174:0.009861:0.009085:0.011596:0.010843:0.005547:0.011391:0.007989:0.005250:0.005615:0.011596:0.009039:0.007670:0.007989:0.011322:0.009039:0.007807:0.005547:0.009633:0.009108:0.011391:0.007989:0.006414:0.007442:0.010843:0.017645:0.007989:0.010843:0.011596:0.009039:0.007989:0.011071:0.007807:0.005615:0.017577:0.009085:0.008400:0.009724:0.007989:0.009085:0.011596:0.011391:0.007989:0.006620:0.011459:0.007442:0.009108:0.009039:0.007989:0.017485:0.009131:0.006551:0.009291:0.007510:0.006551:0.008811:0.006437:0.005547:0.008994:0.007989:0.007601:0.005273:0.006209:0.009039:0.007670:0.007989:0.010843:0.006209:0.007989:0.009291:0.007989:0.011365:0.008813:0.006437:0.005547:0.009039:0.011391:0.006437:0.007989:0.011391:0.005798:0.009199:0.009859:0.007533
nosed with LGS OC (:@0.117647:0.840126:0.312175:0.840126:0.312175:0.819753:0.117647:0.819753:0.011596:0.010957:0.007875:0.009108:0.011391:0.007453:0.014723:0.005273:0.006620:0.011459:0.007453:0.011528:0.015682:0.010112:0.007453:0.016778:0.014678:0.007451:0.006939
Figure 4a:@0.312174:0.840126:0.398413:0.840126:0.398413:0.818993:0.312174:0.818993:0.011596:0.006209:0.010751:0.011893:0.008263:0.009473:0.007282:0.010911:0.009861
). CNV analysis revealed losses and gains shared by :@0.398417:0.840126:0.857053:0.840126:0.857053:0.819753:0.398417:0.819753:0.006939:0.004497:0.007453:0.014678:0.016230:0.015089:0.007451:0.009085:0.011690:0.009402:0.005182:0.009724:0.007601:0.005615:0.007670:0.007453:0.007442:0.009336:0.009633:0.009291:0.009405:0.005182:0.009108:0.011391:0.007453:0.005182:0.010957:0.007533:0.007875:0.009039:0.007670:0.007451:0.009085:0.011598:0.011391:0.007453:0.009861:0.009087:0.005615:0.011619:0.007670:0.007453:0.007556:0.011391:0.009087:0.007442:0.009106:0.011391:0.007453:0.010843:0.009724:0.004109
all tumor lesions from the same patient (for example, loss of chromosome X) as well :@0.117647:0.860704:0.857027:0.860704:0.857027:0.840331:0.117647:0.840331:0.009405:0.005387:0.005250:0.006620:0.006163:0.011413:0.017485:0.010843:0.007807:0.006620:0.005182:0.009039:0.007601:0.005547:0.010843:0.011619:0.007670:0.006620:0.006414:0.007442:0.010843:0.017645:0.006620:0.006617:0.011302:0.009039:0.006620:0.007944:0.009085:0.017485:0.009039:0.006620:0.011368:0.008811:0.006437:0.005547:0.009039:0.011391:0.006437:0.006620:0.006939:0.006024:0.010843:0.007807:0.006620:0.009108:0.010089:0.009085:0.017280:0.011162:0.005182:0.008743:0.004497:0.006620:0.005182:0.010957:0.007533:0.007670:0.006620:0.010843:0.006209:0.006620:0.008765:0.011459:0.007442:0.010843:0.017485:0.010957:0.007875:0.010843:0.017485:0.009039:0.006620:0.014107:0.006939:0.006620:0.009291:0.007670:0.006620:0.014518:0.008948:0.005387:0.005250:0.004109
as copy number changes only present in the metastatic sites (for example, loss of 17p :@0.117647:0.881283:0.857130:0.881283:0.857130:0.860910:0.117647:0.860910:0.009291:0.007670:0.006346:0.008994:0.010820:0.011092:0.009724:0.006346:0.011391:0.011413:0.017394:0.011254:0.009039:0.007807:0.006346:0.008765:0.011391:0.009085:0.011459:0.009656:0.009039:0.007670:0.006346:0.010843:0.011870:0.005182:0.009724:0.006334:0.011071:0.007442:0.009039:0.007875:0.009039:0.011391:0.006437:0.006346:0.005615:0.011756:0.006334:0.006620:0.011299:0.009039:0.006346:0.017485:0.009131:0.006551:0.009291:0.007510:0.006551:0.008811:0.006437:0.005547:0.008994:0.006334:0.007601:0.005273:0.006209:0.009039:0.007670:0.006346:0.006939:0.006026:0.010843:0.007807:0.006334:0.009108:0.010089:0.009085:0.017280:0.011162:0.005182:0.008743:0.004497:0.006346:0.005182:0.010957:0.007533:0.007670:0.006346:0.010843:0.006209:0.006334:0.010432:0.010432:0.011276:0.004109
in LGS-1.2,3,4; :@0.117647:0.901862:0.250086:0.901862:0.250086:0.881489:0.117647:0.881489:0.005615:0.011756:0.006391:0.011525:0.015682:0.010112:0.007533:0.010432:0.004497:0.010432:0.004497:0.010432:0.004497:0.010432:0.004497:0.004109
Figure 4a:@0.252380:0.901862:0.337593:0.901862:0.337593:0.880729:0.252380:0.880729:0.011596:0.006209:0.010751:0.011893:0.008263:0.009473:0.006255:0.010911:0.009861
). These CNVs are conserved between tumor tissue and the :@0.337593:0.901862:0.856991:0.901862:0.856991:0.881489:0.337593:0.881489:0.006939:0.004497:0.006391:0.011470:0.011311:0.009039:0.007875:0.009039:0.006391:0.014678:0.016230:0.015089:0.007670:0.006391:0.009085:0.007442:0.009039:0.006391:0.008994:0.010843:0.011619:0.007875:0.009039:0.008398:0.009633:0.009108:0.011391:0.006391:0.011254:0.009131:0.006437:0.014518:0.009108:0.009039:0.011756:0.006391:0.006163:0.011413:0.017485:0.010843:0.007807:0.006391:0.006437:0.005615:0.007533:0.007510:0.011345:0.009039:0.006391:0.009085:0.011596:0.011391:0.006391:0.006620:0.011299:0.009039:0.004109
Figure 4- Somatic mutations and amplications/ deletions in OC organoids :@0.127256:0.271461:0.721462:0.271461:0.721462:0.255215:0.127256:0.255215:0.008797:0.004465:0.010667:0.010514:0.006049:0.009560:0.004045:0.009789:0.005858:0.004045:0.009522:0.010476:0.015914:0.009121:0.006316:0.004465:0.008549:0.004045:0.015914:0.010514:0.006316:0.009121:0.006316:0.004465:0.010476:0.010590:0.007556:0.004045:0.009197:0.010590:0.010762:0.004045:0.009197:0.015914:0.010857:0.004503:0.004465:0.009980:0.008549:0.009121:0.006316:0.004465:0.010476:0.010590:0.007556:0.006545:0.004045:0.010762:0.009560:0.004503:0.009560:0.006316:0.004465:0.010476:0.010590:0.007556:0.004045:0.004465:0.010590:0.004045:0.013147:0.011067:0.004045:0.010476:0.006087:0.010667:0.009197:0.010590:0.010476:0.004465:0.010762:0.007556:0.004045
MBT-1:@0.125002:0.304969:0.156055:0.304969:0.156055:0.294812:0.125002:0.294812:0.009591:0.006359:0.005321:0.003662:0.006120
AGO2:@0.187031:0.602970:0.187031:0.582309:0.172692:0.582309:0.172692:0.602970:0.007122:-0.380603:0.000000:0.402650
AHNAK2:@0.196277:0.612637:0.196277:0.582309:0.181937:0.582309:0.181937:0.612637:0.000000:0.000000:0.000000:0.000000:0.000000:0.042816
Inframe:@0.783892:0.484302:0.822485:0.484302:0.822485:0.474145:0.783892:0.474145:0.002971:0.006621:0.003483:0.003841:0.005750:0.009949:0.005977
    insertion:@0.783892:0.491063:0.838219:0.491063:0.838219:0.480905:0.783892:0.480905:0.002529:0.002529:0.002529:0.002529:0.002792:0.006621:0.004724:0.005977:0.004186:0.003949:0.002792:0.006549:0.006621
APOB:@0.205534:0.602379:0.205534:0.582309:0.191194:0.582309:0.191194:0.602379:0.000000:0.000000:0.000000:0.028333
ARID1A:@0.214779:0.609181:0.214779:0.582309:0.200440:0.582309:0.200440:0.609181:0.000000:0.000000:0.000000:0.000000:0.000000:0.037936
ATR:@0.224025:0.595576:0.224025:0.582309:0.209685:0.582309:0.209685:0.595576:0.000000:0.012312:0.006418
AURKA:@0.233270:0.607094:0.233270:0.582309:0.218931:0.582309:0.218931:0.607094:0.006967:-0.328388:0.000000:0.349110:0.007301
BCORL1:@0.242540:0.610305:0.242540:0.582309:0.228200:0.582309:0.228200:0.610305:0.000000:0.013135:-0.320753:0.000000:0.000000:0.347141
BRAF:@0.251785:0.600765:0.251785:0.582309:0.237445:0.582309:0.237445:0.600765:0.000000:0.012944:-0.324785:0.337896
BRCA1:@0.261043:0.605902:0.261043:0.582309:0.246703:0.582309:0.246703:0.605902:0.000000:0.012920:0.006967:-0.315217:0.328638
BRCA2:@0.270288:0.605902:0.270288:0.582309:0.255948:0.582309:0.255948:0.605902:0.000000:0.012920:0.006967:-0.305972:0.319393
CCNE1:@0.279534:0.605987:0.279534:0.582309:0.265194:0.582309:0.265194:0.605987:0.006669:-0.283389:0.000000:0.000000:0.310147
CDK12:@0.288779:0.606088:0.288779:0.582309:0.274440:0.582309:0.274440:0.606088:0.000000:0.000000:0.000000:0.000000:0.033570
CDKN2A:@0.298036:0.612485:0.298036:0.582309:0.283697:0.582309:0.283697:0.612485:0.000000:0.000000:0.000000:0.000000:0.000000:0.042601
CDKN2B:@0.307282:0.611893:0.307282:0.582309:0.292943:0.582309:0.292943:0.611893:0.000000:0.000000:0.000000:0.000000:0.000000:0.041766
CIC:@0.316539:0.594131:0.316539:0.582309:0.302200:0.582309:0.302200:0.594131:0.000000:0.000000:0.016690
CREBBP:@0.325785:0.609570:0.325785:0.582309:0.311445:0.582309:0.311445:0.609570:0.000000:0.000000:0.000000:0.000000:0.000000:0.038485
CSMD3:@0.335042:0.608133:0.335042:0.582309:0.320703:0.582309:0.320703:0.608133:0.000000:0.000000:0.000000:0.000000:0.036457
CXCR1:@0.344288:0.605573:0.344288:0.582309:0.329948:0.582309:0.329948:0.605573:0.000000:0.013385:-0.225935:0.000000:0.245393
DAB2:@0.353545:0.601905:0.353545:0.582309:0.339206:0.582309:0.339206:0.601905:0.007778:-0.216249:0.000000:0.236135
E2F1:@0.362791:0.599252:0.362791:0.582309:0.348451:0.582309:0.348451:0.599252:0.000000:0.000000:0.000000:0.023919
EPPK1:@0.372048:0.604373:0.372048:0.582309:0.357709:0.582309:0.357709:0.604373:0.000000:0.000000:0.000000:0.000000:0.031148
EXT1:@0.381294:0.599894:0.381294:0.582309:0.366954:0.582309:0.366954:0.599894:0.000000:0.012777:-0.196338:0.208387
FAT3:@0.390551:0.598821:0.390551:0.582309:0.376212:0.582309:0.376212:0.598821:0.000000:0.011262:0.005929:0.006120
FAT4:@0.399797:0.598821:0.399797:0.582309:0.385457:0.582309:0.385457:0.598821:0.000000:0.011262:0.005929:0.006120
FGFR1:@0.409042:0.604880:0.409042:0.582309:0.394703:0.582309:0.394703:0.604880:0.000000:0.000000:0.000000:0.000000:0.031864
FGFR2:@0.418288:0.604880:0.418288:0.582309:0.403948:0.582309:0.403948:0.604880:0.000000:0.000000:0.000000:0.000000:0.031864
FLG2:@0.427533:0.599877:0.427533:0.582309:0.413194:0.582309:0.413194:0.599877:0.000000:0.010975:-0.148321:0.162147
GABRA6:@0.436803:0.611615:0.436803:0.582309:0.422463:0.582309:0.422463:0.611615:0.000000:0.000000:0.000000:0.027951:-0.139457:0.152878
GTSE1:@0.446048:0.604576:0.446048:0.582309:0.431709:0.582309:0.431709:0.604576:0.000000:0.013564:-0.125762:0.000000:0.143632
KRAS:@0.455294:0.600815:0.455294:0.582309:0.440954:0.582309:0.440954:0.600815:0.000000:0.012944:-0.121205:0.134387
LRP1B:@0.464551:0.604254:0.464551:0.582309:0.450212:0.582309:0.450212:0.604254:0.000000:0.000000:0.000000:0.000000:0.030981
MAP3K1:@0.473797:0.611936:0.473797:0.582309:0.459457:0.582309:0.459457:0.611936:0.009472:-0.083531:0.000000:0.000000:0.000000:0.115884
MAP3K4:@0.483042:0.611936:0.483042:0.582309:0.468703:0.582309:0.468703:0.611936:0.009472:-0.074285:0.000000:0.000000:0.000000:0.106638
MDC1:@0.492300:0.603967:0.492300:0.582309:0.477960:0.582309:0.477960:0.603967:0.000000:0.000000:0.000000:0.030576
MECOM:@0.501545:0.610601:0.501545:0.582310:0.487206:0.582310:0.487206:0.610601:0.000000:0.000000:0.022128:-0.070323:0.088134
MMP16:@0.510791:0.609063:0.510791:0.582309:0.496451:0.582309:0.496451:0.609063:0.000000:0.000000:0.000000:0.000000:0.037769
MMP26:@0.520036:0.609063:0.520036:0.582309:0.505697:0.582309:0.505697:0.609063:0.000000:0.000000:0.000000:0.000000:0.037769
MYC:@0.529294:0.598272:0.529294:0.582309:0.514954:0.582309:0.514954:0.598272:0.009591:-0.047443:0.060387
MYH1:@0.538539:0.603460:0.538539:0.582309:0.524200:0.582309:0.524200:0.603460:0.000000:0.015962:-0.037243:0.051142
MYH2:@0.547797:0.603460:0.547797:0.582309:0.533457:0.582309:0.533457:0.603460:0.000000:0.015962:-0.027986:0.041884
NDRG1:@0.557042:0.607863:0.557042:0.582309:0.542702:0.582309:0.542702:0.607863:0.000000:0.000000:0.022249:-0.018812:0.032639
NF1:@0.566300:0.596320:0.566300:0.582309:0.551960:0.582309:0.551960:0.596320:0.000000:0.000000:0.019779
NRAS:@0.575545:0.601795:0.575545:0.582309:0.561205:0.582309:0.561205:0.601795:0.000000:0.014328:-0.000953:0.014136
PARK2:@0.584802:0.604728:0.584802:0.582309:0.570463:0.582309:0.570463:0.604728:0.005345:0.021427:0.000000:0.000000:0.004878
PARP1:@0.594048:0.604643:0.594048:0.582309:0.579708:0.582309:0.579708:0.604643:0.005345:0.030553:0.000000:0.000000:-0.004367
PIK3CA:@0.603305:0.607846:0.603305:0.582309:0.588966:0.582309:0.588966:0.607846:0.000000:0.000000:0.000000:0.000000:0.028751:0.007301
PLEC:@0.612563:0.599852:0.612563:0.582309:0.598223:0.582309:0.598223:0.599852:0.000000:0.000000:0.000000:0.024766
PPP1R3A:@0.621808:0.614184:0.621808:0.582309:0.607469:0.582309:0.607469:0.614184:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.044999
PPP2R1A:@0.631054:0.614184:0.631054:0.582309:0.616714:0.582309:0.616714:0.614184:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.044999
PRKC1:@0.640311:0.605024:0.640311:0.582309:0.625972:0.582309:0.625972:0.605024:0.000000:0.000000:0.019028:0.063670:-0.050631
PTEN:@0.649569:0.600722:0.649569:0.582309:0.635229:0.582309:0.635229:0.600722:0.000000:0.000000:0.000000:0.025995
PTK2:@0.658814:0.599920:0.658814:0.582309:0.644475:0.582309:0.644475:0.599920:0.000000:0.000000:0.000000:0.024861
RASA1:@0.668060:0.605742:0.668060:0.582309:0.653720:0.582309:0.653720:0.605742:0.006478:0.104982:0.000000:0.000000:-0.078379
RB1:@0.677317:0.595770:0.677317:0.582309:0.662978:0.582309:0.662978:0.595770:0.000000:0.000000:0.019004
RECQL4:@0.686563:0.609882:0.686563:0.582310:0.672223:0.582310:0.672223:0.609882:0.000000:0.000000:0.018955:0.116854:0.000000:-0.096883
RPTOR:@0.695808:0.605691:0.695808:0.582309:0.681469:0.582309:0.681469:0.605691:0.000000:0.000000:0.018372:0.120765:-0.106128
SLC19A1:@0.705066:0.613212:0.705066:0.582309:0.690726:0.582309:0.690726:0.613212:0.000000:0.011047:0.147965:0.000000:0.000000:0.000000:-0.115385
SYNE1:@0.714311:0.605040:0.714311:0.582309:0.699972:0.582309:0.699972:0.605040:0.000000:0.012252:0.144470:0.000000:-0.124631
TP53:@0.723557:0.599675:0.723557:0.582309:0.709217:0.582309:0.709217:0.599675:0.000000:0.000000:0.000000:0.024516
TP53BP1:@0.732814:0.613085:0.732814:0.582309:0.718475:0.582309:0.718475:0.613085:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.043448
TRIOBP:@0.742060:0.607973:0.742060:0.582309:0.727720:0.582309:0.727720:0.607973:0.000000:0.000000:0.000000:0.000000:0.000000:0.036230
USH2A:@0.751317:0.606959:0.751317:0.582309:0.736978:0.582309:0.736978:0.606959:0.000000:0.000000:0.000000:0.000000:0.034799
WWOX:@0.760563:0.607161:0.760563:0.582309:0.746223:0.582309:0.746223:0.607161:0.010283:0.010093:0.185591:-0.170882
MBT-2.2:@0.125002:0.316839:0.164645:0.316839:0.164645:0.306682:0.125002:0.306682:0.009591:0.006359:0.005321:0.003662:0.006120:0.002469:0.006120
MBT-2.1:@0.125002:0.326016:0.164645:0.326016:0.164645:0.315859:0.125002:0.315859:0.009591:0.006359:0.005321:0.003662:0.006120:0.002469:0.006120
MC-1.2:@0.125002:0.338125:0.159885:0.338125:0.159885:0.327968:0.125002:0.327968:0.009591:0.006919:0.003662:0.006120:0.002469:0.006120
MC-1.1:@0.125002:0.348942:0.159885:0.348942:0.159885:0.338785:0.125002:0.338785:0.009591:0.006919:0.003662:0.006120:0.002469:0.006120
MC-2.2:@0.125002:0.360290:0.159885:0.360290:0.159885:0.350133:0.125002:0.350133:0.009591:0.006919:0.003662:0.006120:0.002469:0.006120
MC-2.1:@0.125002:0.370836:0.159885:0.370836:0.159885:0.360679:0.125002:0.360679:0.009591:0.006919:0.003662:0.006120:0.002469:0.006120
SBT-3.2:@0.125002:0.382159:0.160935:0.382159:0.160935:0.372002:0.125002:0.372002:0.005881:0.006359:0.005321:0.003662:0.006120:0.002469:0.006120
SBT-3.1:@0.125002:0.391962:0.160935:0.391962:0.160935:0.381805:0.125002:0.381805:0.005881:0.006359:0.005321:0.003662:0.006120:0.002469:0.006120
LGS-1.4:@0.125002:0.403902:0.162187:0.403902:0.162187:0.393745:0.125002:0.393745:0.005165:0.007707:0.005941:0.003662:0.006120:0.002469:0.006120
LGS-1.3:@0.125002:0.414634:0.162187:0.414634:0.162187:0.404476:0.125002:0.404476:0.005165:0.007707:0.005941:0.003662:0.006120:0.002469:0.006120
LGS-1.2:@0.125002:0.424622:0.162187:0.424622:0.162187:0.414465:0.125002:0.414465:0.005165:0.007707:0.005941:0.003662:0.006120:0.002469:0.006120
LGS-1.1:@0.125002:0.433494:0.162187:0.433494:0.162187:0.423337:0.125002:0.423337:0.005165:0.007707:0.005941:0.003662:0.006120:0.002469:0.006120
LGS-2.2:@0.125002:0.446491:0.162187:0.446491:0.162187:0.436334:0.125002:0.436334:0.005165:0.007707:0.005941:0.003662:0.006120:0.002469:0.006120
LGS-3.2:@0.125002:0.456978:0.162187:0.456978:0.162187:0.446820:0.125002:0.446820:0.005165:0.007707:0.005941:0.003662:0.006120:0.002469:0.006120
HGS-1:@0.125002:0.470397:0.156211:0.470397:0.156211:0.460239:0.125002:0.460239:0.007778:0.007707:0.005941:0.003662:0.006120
HGS-2:@0.125002:0.483520:0.156211:0.483520:0.156211:0.473362:0.125002:0.473362:0.007778:0.007707:0.005941:0.003662:0.006120
HGS-3.2:@0.125002:0.498792:0.164799:0.498792:0.164799:0.488635:0.125002:0.488635:0.007778:0.007707:0.005941:0.003662:0.006120:0.002469:0.006120
HGS-3.1:@0.125002:0.508670:0.164799:0.508670:0.164799:0.498513:0.125002:0.498513:0.007778:0.007707:0.005941:0.003662:0.006120:0.002469:0.006120
HGS-4.5:@0.125002:0.520053:0.164799:0.520053:0.164799:0.509895:0.125002:0.509895:0.007778:0.007707:0.005941:0.003662:0.006120:0.002469:0.006120
HGS-4.3:@0.125002:0.529956:0.164799:0.529956:0.164799:0.519799:0.125002:0.519799:0.007778:0.007707:0.005941:0.003662:0.006120:0.002469:0.006120
HGS-4.1:@0.125002:0.540680:0.164799:0.540680:0.164799:0.530522:0.125002:0.530522:0.007778:0.007707:0.005941:0.003662:0.006120:0.002469:0.006120
HGS-5.1:@0.125002:0.552087:0.164799:0.552087:0.164799:0.541930:0.125002:0.541930:0.007778:0.007707:0.005941:0.003662:0.006120:0.002469:0.006120
HGS-6:@0.125002:0.564754:0.156210:0.564754:0.156210:0.554597:0.125002:0.554597:0.007778:0.007707:0.005941:0.003662:0.006120
HGS-19:@0.125002:0.578435:0.162330:0.578435:0.162330:0.568278:0.125002:0.568278:0.007778:0.007707:0.005941:0.003662:0.006120:0.006120
Frameshift:@0.785502:0.441551:0.838219:0.441551:0.838219:0.431393:0.785502:0.431393:0.005500:0.003841:0.005750:0.009949:0.005977:0.004724:0.006621:0.002792:0.003615:0.003949
Gain:@0.775947:0.377024:0.798912:0.377024:0.798912:0.366867:0.775947:0.366867:0.007802:0.005750:0.002792:0.006621
Loss:@0.775947:0.396130:0.797409:0.396130:0.797409:0.385973:0.775947:0.385973:0.005464:0.006549:0.004724:0.004724
Missense:@0.792947:0.420205:0.838220:0.420205:0.838220:0.410048:0.792947:0.410048:0.009735:0.002792:0.004724:0.004724:0.005977:0.006621:0.004724:0.005977
Stop gain:@0.790800:0.462760:0.838220:0.462760:0.838220:0.452603:0.790800:0.452603:0.005846:0.003877:0.006549:0.006788:0.002529:0.006669:0.005750:0.002792:0.006621
Tumor:@0.787235:0.303067:0.819603:0.303067:0.819603:0.292909:0.787235:0.292909:0.005393:0.006574:0.009950:0.006550:0.003901
Org. 1:@0.787223:0.315329:0.816859:0.315329:0.816859:0.305171:0.787223:0.305171:0.008220:0.003806:0.006490:0.002470:0.002529:0.006120
st:@0.816859:0.311049:0.823792:0.311049:0.823792:0.302930:0.816859:0.302930:0.003776:0.003156
Org. 2:@0.787224:0.327594:0.816860:0.327594:0.816860:0.317436:0.787224:0.317436:0.008220:0.003806:0.006490:0.002470:0.002529:0.006120
nd:@0.816859:0.323311:0.827530:0.323311:0.827530:0.315193:0.816859:0.315193:0.005292:0.005378